cancer research

Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Thomas R et al. - These data suggest that if patients suffering significant adverse effects on T are given the opportunity to try an AI, this empowers them to prioritise relative side-effects, improving wellbeing in a significant proportion. These data also highlight the need for hospital follow-up in this intolerant cohort.


   

Today in Hematology/Oncology...keeping you current

FDA Drug Approval Summary: Bevacizumab plus Interferon for Advanced Renal Cell Carcinoma
The Oncologist, 02/09/10

Cancer epidemiology in France in 2010, comparison with the USA
Bulletin du Cancer, 02/09/10

Rectal cancer and adjuvant chemotherapy: which conclusions
Bulletin du Cancer, 02/09/10

Today in Women`s Health...keeping you current

Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis
Osteoporosis International, 02/09/10

Another treatment gap: Restarting secondary prevention medications: The Womens Health Initiative
Journal of Clinical Lipidology, 02/09/10

Positive celiac disease serology and reduced bone mineral density in adult women
Canadian Journal of Gastroenterology, 02/09/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address